Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 883

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Interleukin‐6 in Covid‐19: A systematic review and meta‐analysis

Open access
Coomes, Eric A., Haghbayan, Hourmazd·2020·Reviews in Medical Virology

Published version of a preprint

Abstract

Summary: Coronaviruses may activate dysregulated host immune responses. As exploratory studies have suggested that interleukin‐6 (IL‐6) levels are elevated in cases of complicated Covid‐19, we undertook a systematic review and meta‐analysis to assess the evidence in this field. We systematically searched MEDLINE and EMBASE for studies investigating the immunological response in Covid‐19; additional grey literature searches were undertaken. Study selection and data abstraction was undertaken independently by two authors. Meta‐analysis was undertaken using random effects models to compute ratios of means with 95% confidence intervals (95%CIs). Eight published studies and two preprints (n = 1798) were eligible for inclusion. Meta‐analysis of mean IL‐6 concentrations demonstrated 2.9‐fold higher levels in patients with complicated Covid‐19 compared with patients with noncomplicated disease (six studies; n = 1302; 95%CI, 1.17‐7.19; I 2 = 100%). Consistent results were found in sensitivity analyses exclusively restricted to studies comparing patients requiring ICU admission vs no ICU admission (two studies; n = 540; ratio of means = 3.24; 95%CI, 2.54‐4.14; P < .001; I 2 = 87%). Nine of ten studies were assessed to have at least moderate risk of bias. In patients with Covid‐19, IL‐6 levels are significantly elevated and associated with adverse clinical outcomes. Inhibition of IL‐6 may be a novel target for therapeutics for the management of dysregulated host responses in patients with Covid‐19 and high‐quality studies of intervention in this field are urgently required.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/rmv.2141

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 2

  1. KhanF FabbriL StewartI RobinsonK SmythAR JenkinsG.A systematic review of anakinra tocilizumab sarilumab and siltuximab for coronavirus‐related infections.medRxiv. 2020; 20076612. doi:https://doi.org/10.1101/2020.04.23.20076612. · doi:10.1101/2020.04.23.20076612
  2. GrittiG RaimondiF RipamontiD et al.Use of in patients with COVID‐19 pneumonia requiring ventilatory support.medRxiv. 2020; 20048561. doi:https://doi.org/10.1101/2020.04.01.20048561. · DOI

Cited by

See all 883

Metadata

Authors
Coomes, E. A., & Haghbayan, H.
Venue
Reviews in Medical Virology
Publisher
Wiley
Published
2020-08-26
Volume
30
Issue
6
Pages
1-9
ISSN
  • 1052-9276 (ISSN-L)
  • 1099-1654
OpenAlex
W3081502886
Cited by
883
References
51
FWCI
9.69
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.